Authors
Latest:
A Roadmap to Optimizing Marketing OperationsUnifying a company’s approach to marketing fulfillment activities could provide innovation while delivering cost savings
Latest:
A New Business Model for Pharma InnovationThe studio model: how film industry practices can boost pharmaceutical creativity
Latest:
ACOs raise the stakes for evidence-based medicineManufacturers will need to refine their interactions with healthcare providers and produce better outcomes research and adherence programs to compete
Latest:
Is your corporate board equipped to monitor incentive programs?Compliance officers at pharma companies need to ensure that the right mechanisms are in place for monitoring sales and business incentives
Latest:
A New Business Model for Pharma InnovationThe studio model: how film industry practices can boost pharmaceutical creativity
Latest:
The potential of translational research for new medicinesThe proposed federal National Center for Advancing Translational Sciences holds promise for drug development
Latest:
Legal uncertainties in the DSCSAThe Drug Supply Chain Security Act creates uncertainty about which trading partners have responsibility for product verification
Latest:
Accelerating the drive toward patient centricityGetting away from the traditional product-centric management structure is not easy; here’s how to do it
Latest:
Medical-Claims Database Analysis of Off-Label PrescribingExamining off-label use of highly prescribed drugs reveals factors that differ from the usual criticism of such usage
Latest:
Organizing Your Commercial Compliance ProgramsRegulatory attention has intensified over commercial activities. Here’s what to do to minimize risks and raise compliance levels
Latest:
How to prepare a cold chain for looming COVID-19 demandsAgile approaches to averting vaccine wastage will be critical to global delivery ramp-up
Latest:
Include the sales force in incentive compensationBy working with the sales force, incentive plan design can boost a product launch
Latest:
Adopting the TAPA cargo security standards in the pharmaceutical industrySecuring your supply chain
Latest:
Supply chain issues for 2012Tompkins International's annual preview of key pharma supply chain issues
Latest:
Getting from multichannel marketing to customer-centric marketingToday's pharma marketers have the tools to refine their communication efforts to prescribers and patients
Latest:
Rethinking Sample DistributionAs the number of specific services associated with sample distribution has grown, so has the number of service providers a manufacturer might use. It’s time to think about consolidating these services
Latest:
When serializing packages for e-pedigree, go randomThe looming California e-pedigree standards do not specify how to generate product codes, but random codes are easy to produce and essential for supply chain security
Latest:
Artificial Intelligence: Beyond the glamorIt takes gritty work to make an AI application succeed—but it can be worth the effort
Latest:
Gaining Access to the European MarketDistributing products within the European market calls for focused knowledge of national practices
Latest:
The value of real-world data in drug commercializationUsing real-world databases for evidence development has strengths and weaknesses; with electronic health records (EHRs), new approaches are evolving
Latest:
Pharma is under-managing its multi-channel marketing effortsSurvey shows that most digital channels are still experiments with little oversight or follow-through
Latest:
Economic and clinical value: the future of cancer careAn 'expectations convergence' is building in how drug efficacy aligns with patient outcomes
Latest:
A Data-Driven Approach to Contract Performance Monitoring and AnalysisBetter use of available data can add rigor to analyzing managed-markets contracts, thereby allocating rebates / discounts more effectively
